Chengdu Shengnuo Biopharmaceutical Co., LTD., a wholly-owned subsidiary of Chengdu Shengnuo Biotechnology Co., LTD., was established in October 2004 as a high-tech certification enterprise in Sichuan Province with a registered capital of 50 million yuan. With more than 50 key technologies for large-scale production of peptides that have been listed at home and abroad, it is a first-class professional, large-scale peptide and amino acid drug manufacturer in China, and the leader in the domestic peptide industry with a single batch output of KG;